**INTRODUCTION:** Lipofilling is gaining more and more popularity in plastic surgery. However, currently the tumorigenicity and angiogenic properties of lipoaspirates for correction of volume defects after breast conserving therapy, is discussed controversially. To assess the safety of lipotransfer into remaining breast tissue, the interaction of primary adipose derived stem cells (ADSC) and mammary epithelial cells (MEC) is evaluated in this study.

**Material and Methods:** MEC and ADSC were isolated from human breast tissue and characterized by immunohistochemistry, real-time PCR and differentiation. Paracrine and cell-cell interactions of ADSC and MEC were evaluated using ADSC conditioned medium (CM) and direct/indirect co-cultures. A range of functional analyses of MEC was performed such as migration, transmigration, proliferation, invasion as well as gene expression of MEC. The secretion profile of ADSC was analyzed using an antibody array/ELISA.

**RESULTS:** Protocols for isolation and characterization of MEC and ADSC from breast tissue could be established successfully. Transmigration of MEC significantly increased when cultivated in ADSC CM while 2D migration and proliferation increased moderately. Preliminary results revealed cell fusions of ADSC and MEC in co-cultures. In ongoing experiments changes of gene expression of MEC after ADSC stimulation are investigated. Analysis of ADSC CM revealed distinct proteins and growth factors that could be responsible for MEC stimulation, e.g. fibronectin, Il-6, MCP-1, Clusterin, and ENPP2.

**CONCLUSIONS:** A more detailed understanding of ADSC-MEC interactions would help to assess the risk of using ADSC for regenerative purposes such as lipotransfer into remaining breast tissue after tumor excision. Finally these results indicate that ADSC are capable of transforming MEC into a stimulated stage. Further studies are required to evaluate the potential risk of cell-assisted lipotransfer directly inducig breast cancer recurrence as well as de novo formation. Moreover, detailed assessments of the cell-cell interplay could be decisive for developing new breast cancer therapies.
